TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
1-Year Return
21.62%
This Quarter Return
+2.99%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$671M
AUM Growth
-$17.2M
(-2.5%)
Cap. Flow
+$111M
Cap. Flow
% of AUM
16.56%
Top 10 Holdings %
Top 10 Hldgs %
38.66%
Holding
127
New
38
Increased
29
Reduced
15
Closed
24
Top Buys
| 1 |
Novo Nordisk
NVO
|
$21.5M |
| 2 |
Evolus
EOLS
|
$20.2M |
| 3 |
BLUE
bluebird bio
BLUE
|
$16.7M |
| 4 |
FLG
Flagstar Financial, Inc.
FLG
|
$14.5M |
| 5 |
Adicet Bio
ACET
|
$11.1M |
Top Sells
| 1 |
AnaptysBio
ANAB
|
$13M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$12M |
| 3 |
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
|
$8.9M |
| 4 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
$6.72M |
| 5 |
Cytokinetics
CYTK
|
$5.04M |
Sector Composition
| 1 | Healthcare | 91.26% |
| 2 | Financials | 6.75% |
| 3 | Real Estate | 0.31% |
| 4 | Consumer Discretionary | 0.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
MEI Pharma
MEIP
$140M
| $1.18M | 0.18% |
+258,173
| New | +$1.18M |
|
77
UMB Financial
UMBF
$9.39B
| $1.15M | 0.17% |
+20,000
| New | +$1.15M |
|
78
SCYNEXIS
SCYX
$36.4M
| $1.15M | 0.17% |
+383,179
| New | +$1.15M |
|
|
SURF
79
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $908K | 0.14% |
1,300,000
+870,353
| +203% | +$608K |
|
80
Athira Pharma
ATHA
$15.3M
| $882K | 0.13% |
352,715
-132,519
| -27% | -$331K |
|
81
Heron Therapeutics
HRTX
$202M
| $831K | 0.12% |
550,000
-3,205,934
| -85% | -$4.84M |
|
82
Tango Therapeutics
TNGX
$760M
| $790K | 0.12% |
+200,000
| New | +$790K |
|
83
Vanda Pharmaceuticals
VNDA
$274M
| $679K | 0.1% |
+100,000
| New | +$679K |
|
84
Tonix Pharmaceuticals
TNXP
$231M
| $650K | 0.1% |
55
-170
| -76% | -$2.01M |
|
85
NextCure
NXTC
$13.2M
| $592K | 0.09% |
+33,333
| New | +$592K |
|
86
Invivyd
IVVD
$209M
| $480K | 0.07% |
+400,000
| New | +$480K |
|
|
LIAN
87
DELISTED
LianBio American Depositary Shares
LIAN
| $411K | 0.06% |
209,600
+150,000
| +252% | +$294K |
|
|
PRDS
88
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $396K | 0.06% |
300,000
+266,252
| +789% | +$351K |
|
89
Inspirato
ISPO
$36.5M
| $364K | 0.05% |
+19,000
| New | +$364K |
|
|
KRON
90
DELISTED
Kronos Bio
KRON
| $292K | 0.04% |
+200,000
| New | +$292K |
|
91
Passage Bio
PASG
$22.3M
| $287K | 0.04% |
+15,000
| New | +$287K |
|
|
ORTX
92
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $269K | 0.04% |
50,000
-150,000
| -75% | -$806K |
|
|
ATYR
93
aTyr Pharma
ATYR
$536M
| $259K | 0.04% |
123,430
| – | – |
|
94
Stellar Bancorp
STEL
$1.61B
| $246K | 0.04% |
+10,000
| New | +$246K |
|
|
MOLN
95
Molecular Partners
MOLN
$133M
| $231K | 0.03% |
38,253
+16,253
| +74% | +$98.1K |
|
96
Reviva Pharmaceuticals
RVPH
$30.4M
| $223K | 0.03% |
53,200
+29,075
| +121% | +$122K |
|
|
CYT
97
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $182K | 0.03% |
+100,000
| New | +$182K |
|
98
Instil Bio
TIL
$205M
| $132K | 0.02% |
+10,000
| New | +$132K |
|
99
Talphera
TLPH
$10.6M
| $128K | 0.02% |
195,000
| – | – |
|
|
VINC
100
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $106K | 0.02% |
5,088
| – | – |
|